Archives

Major Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)
About This Event
Major Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)
Major depressive disorder affects more than 260 million people worldwide.1 The reported prevalence of depression in patients with chronic kidney disease ranges from 20-65%.2 This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology.
1. World Health Organization. Fact Sheet on Depression. (2012) https://www.who.int/health-topics/depression#tab=tab_1
2. Teles F et al. Clinics (Sao Paulo). 2014 ;69(3):198-202.
Maggiano’s Little Italy Oak Brook
Oak Brook, Illinois 60523 United States + Google Map

Jaimini Patel, PharmD, BCCCP
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Jaimini Patel, PharmD, BCCCP, is a Nephrology Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Patel earned her Doctorate in Pharmacy from the University of Michigan, Ann Arbor and completed two years of post-doctoral residency at Beaumont Hospital, Royal Oak and Loyola University Medical Center, respectively, specializing in critical care pharmacy practice. Prior to joining Otsuka, Dr Patel practiced as a critical care pharmacist at the Cleveland Clinic Akron General Medical Center for 3.5 years and has cared for patients in the medical, surgical/trauma, cardiothoracic and neuroscience ICUs, and was significantly involved in the care of patients with COVID-19. Dr Patel holds board certification in critical care pharmacotherapy and is a licensed pharmacist in Michigan, Illinois and Ohio. She is also an active member of the Society of Critical Care Medicine through which she is engaged in research and leadership.

Heather Fields, PharmD, MPH, BCACP
Otsuka Pharmaceutical Development & Commercialization, Inc.*
*Drs Patel and Fields are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).